CPC C07K 16/2803 (2013.01) [G01N 33/56966 (2013.01); G01N 33/56972 (2013.01); A61K 2039/505 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/565 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); C07K 2317/76 (2013.01); C07K 2317/77 (2013.01); G01N 2333/70503 (2013.01); G01N 2800/24 (2013.01); G01N 2800/52 (2013.01); G01N 2800/7095 (2013.01)] | 7 Claims |
1. A method for the treatment of a patient having a KIR3DL2-expressing T cell lymphoma, the method comprising administering to said patient an effective amount of a composition comprising an antibody having (i) heavy chain CDRs 1, 2 and 3 (HCDR1, HCDR2, HCDR3), according to the Kabat definition, of the heavy chain variable region sequence of SEQ ID NO: 13, and (ii) light chain CDRs 1, 2 and 3 (LCDR1, LCDR2, LCDR3), according to the Kabat definition, of the light chain variable region sequence of SEQ ID NO: 14.
|